| Name | GLL398 |
|---|
| Description | GLL398, an orally active selective estrogen receptor degrader (SERD), competitively binds to the estrogen receptor with an IC50 value of 1.14 nM. GLL398 exhibits a strong dose-dependent binding profile for the ER with a Y537S point mutation (IC50= 29.5 nM). GLL398 blocks tumor growth in xenograft breast cancer models[1]. |
|---|---|
| Related Catalog | |
| In Vitro | GLL398 is a boron-modified GW5638 analog[1]. |
| References |
| No Any Chemical & Physical Properties |